FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY
K Number: K011162
·
Decision May 2, 2001
Classifications
1
FEI Numbers
97
Registration Numbers
97
Same Product Code
144
Applicant Total
19
Review Days
16
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY
- K Number
- K011162
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 862.3250
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Syva Co., Dade Behring, Inc.
- Date Received
- April 16, 2001
- Decision Date
- May 2, 2001
- Product Code
- DIO
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DIO | Enzyme Immunoassay, Cocaine And Cocaine Metabolites | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DIO), ordered by most recent decision date.
Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DRI Cocaine Metabolite Assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Pointe Scientific Cocaine Metabolite Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DRI Cocaine Metabolite Assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Emit II Plus Cocaine Metabolite Assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Syva Co., Dade Behring, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K011920 | EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229 | Jul 2, 2001 | Substantially Equivalent |
| K011620 | EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229 | Jun 18, 2001 | Substantially Equivalent |
| K011605 | EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229 | Jun 12, 2001 | Substantially Equivalent |
| K011300 | EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229 | May 17, 2001 | Substantially Equivalent |
| K011306 | EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229 | May 16, 2001 | Substantially Equivalent |
| K011161 | MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229 | May 15, 2001 | Substantially Equivalent |
| K011289 | EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229 | May 15, 2001 | Substantially Equivalent |
| K011163 | MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229 | May 10, 2001 | Substantially Equivalent |
| K011166 | MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229 | May 10, 2001 | Substantially Equivalent |
| K011164 | MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229 | May 10, 2001 | Substantially Equivalent |